Loading organizations...
Loading organizations...
Soundsafe Care develops advanced medical technology, integrating ultrasound and robotics to create innovative surgical solutions. Its core offering is a robotic device engineered to facilitate precise, non-invasive surgical procedures, aiming to fundamentally change traditional approaches to surgery, particularly within oncology. This blend of technologies enables enhanced accuracy and minimizes invasiveness, offering a sophisticated alternative to conventional methods.
The company was founded in 2023 by Andrea Mariani in Milan, Italy. Mariani's vision stemmed from the insight that combining the detailed imaging capabilities of ultrasound with the precise manipulation of robotics could address critical limitations in existing surgical techniques, paving the way for safer and more effective patient interventions.
Soundsafe Care’s technology is designed for surgeons and healthcare institutions seeking state-of-the-art tools for delicate procedures. The company’s long-term vision is to revolutionize surgical care, making complex treatments, such as those for liver cancer, significantly safer and more accessible, thereby improving global patient outcomes through technological advancement.
Soundsafe Care has raised $2.0M across 1 funding round.
Soundsafe Care has raised $2.0M in total across 1 funding round.
Soundsafe Care has raised $2.0M in total across 1 funding round.
Soundsafe Care's investors include CDP Venture Capital.
Soundsafe Care is an Italian MedTech startup founded in 2023 that develops a robotic medical device combining focused ultrasound and robotics for non-invasive tumor ablation surgery, primarily targeting oncology in human and veterinary medicine.[1][2][5] The device addresses liver cancer and other tumors by delivering precise, incision-free treatments that minimize side effects, reduce hospital costs, and shorten intervention times through advanced imaging and automation, serving oncologists, surgeons, and patients seeking alternatives to traditional invasive procedures.[2][4][5] With early momentum including a €1.75 million seed round in November 2023 from investors like Pariter Partners and CDP Venture Capital, plus wins like the 2024 Startup Marathon first prize and best female-led startup award, the company is advancing toward commercialization.[1][4][5]
Soundsafe Care emerged as a spin-off from the BioRobotics Institute of Scuola Superiore Sant'Anna in Pisa, Italy, in 2023, building on over 10 years (now 11 years per company claims) of research backed by 16 scientific publications, 3 innovation awards (including KUKA Innovation Award), and in-vivo preclinical studies.[2][5] Founders Laura Morchi and Andrea Mariani, both from Pisa with traits like determination and creativity highlighted in profiles, lead the team alongside Vito Papapicco, leveraging the institute's expertise in biomedical robotics.[1][2] The idea stemmed from pioneering focused ultrasound for localized tumor destruction without incisions, gaining early traction through international projects and recognition as a top 10 Italian emerging startup accelerated by a leading university-linked program.[5]
Soundsafe Care rides the wave of non-invasive MedTech innovation, particularly in oncology where liver cancer alone causes over 900,000 deaths yearly, by disrupting traditional surgery with ultrasound-robotics hybrids amid rising demand for precise, cost-effective alternatives.[4][5] Timing aligns with surging investments in surgical robotics and AI-driven imaging, fueled by aging populations, healthcare cost pressures, and post-pandemic focus on minimally invasive tech—market forces amplified by EU deeptech funding and Italy's biotech hubs like Pisa's Navacchio Technology Hub.[1][2][4] As a spin-off from a top research institute, it influences the ecosystem by bridging academia to market, inspiring similar ultrasound applications and elevating Italy's role in global MedTech alongside trends in robotic surgery (e.g., KUKA partnerships).[2][5]
Soundsafe Care is poised for regulatory milestones and first-in-human trials post its €1.75M seed, targeting market entry for liver cancer treatments amid expanding ultrasound robotics adoption.[5] Trends like AI-enhanced precision medicine and veterinary oncology growth will propel it, potentially scaling via partnerships with hospitals and pharma. Its influence could evolve from Italian deeptech leader to global player, humanizing surgery by making non-invasive ablation standard—echoing its origin in decade-long research to truly disrupt oncology care.[2][4][5]
Soundsafe Care has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in November 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2023 | $2.0M Seed | CDP Venture Capital |